glp 1 7 36 CAS 107444-51-9 Designing GLP-1 delivery: structural perspectives

Key takeaway: GLP-1 RAs do not appear to increase pancreatitis risk, and may be associated with improved outcomes if pancreatitis occurs.

Cheaper generics promise wider access, yet specialists flag safety, storage and overuse concerns

The pharmacy benefit manager announced it will cover Lillys Foundayo starting June 1 and Zepbound starting in October, a setback of sorts for rival Novo Nordisk as Wegovy has been preferred.

Fierce Pharma article, 21 January 2023: [7] [8]

The studies involved subjects, rather small numbers in each case, who had diabetes, non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), coronary disease or had kidney transplants

Learn key insights from Dr Angela Kwong on using GLP-1s safely and how Enlighten Me supports lasting, healthy weight loss.